Experts weigh benefits of treating severe childhood obesity against unknown long-term risks
2Sep 22 · 1d ago · 1 article · 1 source · development 2 of 2
Pediatric researchers and practitioners are increasingly viewing GLP-1 drugs as potentially less risky than untreated childhood obesity, which is linked to depression, low self-esteem, heart disease, type 2 diabetes, and life expectancy cuts of up to 42 years. However, questions remain about the drugs' effects on growth, puberty, bone strength, and future reproductive health.
New Scientist
“I worry about these kids who are losing lots of weight and muscle – what's going to be the effect on their strength and their bones when they're older?”
